Journal Article

Mumps Virus: Replication, Immune Response, and the Changing Landscape of Vaccine Effectiveness

Risalvato, Jacquline

2026

Overview

Mumps virus (MuV) is a single-stranded, negative-sense RNA virus of the Family Paramyxoviridae. MuV is a highly contagious human pathogen that causes primarily mild symptoms, including hallmark swelling of the parotid glands. Severe cases can occur, leading to neurological complications, including deafness, meningitis, and encephalitis. The mumps vaccine, now included in combination with measles and rubella vaccines (MMR), was first made available in the 1960s. After its introduction, mumps incidence dropped dramatically to less than 500 cases annually in the US. However, even with long-standing vaccination programs, MuV continues to challenge the landscape of public health due to a resurgence of cases in the past several decades and a still present lack of approved antiviral drugs and treatments available for the disease. This review will explore the biology of MuV, focusing on how MuV replicates and interacts with the host immune system. Recent studies have also shed light on the role of protein phosphorylation in regulating viral RNA synthesis—particularly the dynamic interactions between the nucleoprotein (NP) and phosphoprotein (P)—offering new insights into how the virus controls its replication machinery both mechanistically and through utilizing host cell advantages. We also examine how the immune system responds to mumps infection and vaccination, and how those responses may vary across viral genotypes. Although the Jeryl Lynn vaccine strain has played a key role in controlling mumps for decades, outbreaks among vaccinated individuals have raised questions about the present vaccine’s efficacy against circulating and emerging genotypes and if novel strategies will be required to prevent future outbreaks. We review current epidemiological data, highlighting shifts in MuV transmission and genotype distribution, and discuss the need for updated or genotype-matched vaccines. By connecting molecular virology with real-world trends in disease spread and vaccine performance, this review aims to support ongoing efforts to strengthen mumps control strategies and inform the development of next-generation vaccines.

• Publisher: MDPI AG,Multidisciplinary Digital Publishing Institute (MDPI)
• Subject: Amino acids / Animals / Antiviral agents / Deafness / Disease / Disease spread / Disease transmission / Effectiveness / Encephalitis / Epidemics / Epidemiology / Exocrine glands / Genomes / Genotypes / Glycoproteins / Health aspects / host–virus interactions / Humans / Immune response / Immune system / Immunosuppressive agents / Measles-mumps-rubella vaccine / Meningitis / Mumps / Mumps - epidemiology / Mumps - immunology / Mumps - prevention & control / Mumps - virology / Mumps Vaccine - immunology / mumps virus (MuV) / Mumps virus - genetics / Mumps virus - immunology / Mumps virus - physiology / Neurological complications / Outbreaks / Paramyxoviridae / Phosphorylation / Proteins / Public health / Replication / Review / RNA / RNA virus replication / RNA viruses / Salivary glands / Synthesis / Transcription / Vaccination / Vaccine Efficacy / Vaccines / viral adaptive immune responses / viral innate immune responses / Virus Replication / Viruses